In this work we analyzed cytogenetically 50 patients with primary myelodysplastic syndrome from several hospitals of Rio de Janeiro, Brazil. The frequency of cytogenetic abnormalities was 32%. Patients with refractory anemia, or refractory anemia with ringed sideroblasts, presented normal karyotypes or single abnormalities such as del(5q) or -Y, while patients with refractory anemia with an excess of blasts, refractory anemia with an excess of blasts in transformation or chronic myelomonocytic leukemia showed complex karyotypes and single abnormalities involving chromosomes 7 or 8, which are related to a bad prognosis and an elevated risk of evolution to acute myeloid leukemia.Neste trabalho foram estudados citogeneticamente 50 pacientes de...
[No abstract available]283165Magalhães, S.M.M., Lorand-Metze, I., Síndromes mielodisplásicas: Protoc...
Myelodysplastic Syndromes (MDS) are a heterogeneous group of hematological diseases characterized by...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Bone marrow cytogenetic studies were performed on 93 patients with primary myelodysplastic syndrome ...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoietic s...
Estudamos citogeneticamente 57 pacientes, 33 com LMA primaria, 12 com LMA secundaria e 17 com SMD pr...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoie...
.Myelodysplastic syndrome (MDS) represents a heterogeneous group of hematopoietic disorders, origina...
A series of 94 patients presenting primary refractory anaemia with excess of blasts in transformatio...
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal disorders of haematopoiet...
Objective: Myelodysplastic syndromes (MDS) are a heterogeneous group of malignant clonal hematopoiet...
Nas sindromes mielodisplasicas o estudo do cariotipo e fundamental nao somente ao diagnostico, como ...
O estudo das alteracoes citogeneticas em leucemia mieloide aguda (LMA) e em sindrome mielodisplasica...
A mielofibrose (MF) é a neoplasia mieloproliferativa (NMP) de maior gravidade, com uma sobrevida mui...
This study reports on a cytogenetic finding in a bone marrow examination of a 47-year-old male patie...
[No abstract available]283165Magalhães, S.M.M., Lorand-Metze, I., Síndromes mielodisplásicas: Protoc...
Myelodysplastic Syndromes (MDS) are a heterogeneous group of hematological diseases characterized by...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Bone marrow cytogenetic studies were performed on 93 patients with primary myelodysplastic syndrome ...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoietic s...
Estudamos citogeneticamente 57 pacientes, 33 com LMA primaria, 12 com LMA secundaria e 17 com SMD pr...
Myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML) are rare hematopoie...
.Myelodysplastic syndrome (MDS) represents a heterogeneous group of hematopoietic disorders, origina...
A series of 94 patients presenting primary refractory anaemia with excess of blasts in transformatio...
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal disorders of haematopoiet...
Objective: Myelodysplastic syndromes (MDS) are a heterogeneous group of malignant clonal hematopoiet...
Nas sindromes mielodisplasicas o estudo do cariotipo e fundamental nao somente ao diagnostico, como ...
O estudo das alteracoes citogeneticas em leucemia mieloide aguda (LMA) e em sindrome mielodisplasica...
A mielofibrose (MF) é a neoplasia mieloproliferativa (NMP) de maior gravidade, com uma sobrevida mui...
This study reports on a cytogenetic finding in a bone marrow examination of a 47-year-old male patie...
[No abstract available]283165Magalhães, S.M.M., Lorand-Metze, I., Síndromes mielodisplásicas: Protoc...
Myelodysplastic Syndromes (MDS) are a heterogeneous group of hematological diseases characterized by...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...